Author

Megan S. Laham

University of ArizonaORCID 0000-0002-9803-3323Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Annadurai AnandhaniD· 1 shared Christopher Penton· 1 shared Fahmida AlamiD· 1 shared Ganga Reddy Velma· 1 shared Gregory R. J. ThatcheriD· 1 shared Maha Ibrahim Sulaiman· 1 shared Manan Rana· 1 shared Martha S Ackerman-Berrier· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Annadurai AnandhanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintSep 12, 2025

In search of nonlipogenic ABCA1 inducers (NLAI): precision coregulator TR-FRET identifies diverse signatures for LXR ligands

Megan S. Laham, Martha S Ackerman-Berrier, Fahmida Alam…·Gregory R. J. Thatcher

The paper identifies diverse LXR ligand signatures using TR-FRET assays to guide the design of nonlipogenic ABCA1 inducers.

1 citation

humanproteomics